DUBLIN–( SERVICE CORD)– The “Botulinum Toxic Substance in Urology Market Overview 2026-2034: Market Share and Development Evaluation” has actually been included in ResearchAndMarkets.com’s offering. The Botulinum Toxic Substance in Urology Market is valued at USD 1.02 billion in 2025 and is predicted to expand at a CAGR of 5.7%, getting to USD 1.73 billion by 2034. Botulinum contaminant stays an important interventional treatment in urology, specifically for refractory over active bladder (OAB) and neurogenic detrusor overactivity (NDO), amongst oth
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/botulinum-toxin-in-urology-market-outlook-2026-2034-pipeline-innovations-training-fuel-growth-over-the-forecast-period-researchandmarkets-com/
